Metraipolis › archive › dc_a0c4988aedee
Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives — Europe PMC PMID:41010968
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41010968
- DOI
- 10.3390/medicina61091577
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T06:03:08.859Z
- SHA-256 of the archived text
a6675ea1c0d97b565de621dad7ccd07a24f4c1aaae168377e973cb2abeb4c749- Stable URL of this page
https://metraipolis.com/documento/dc_a0c4988aedee
How to cite
Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives — Europe PMC PMID:41010968 — Europe PMC (en), https://europepmc.org/article/MED/41010968 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a0c4988aedee (Metraipolis archive dc_a0c4988aedee, sha256 a6675ea1c0d97b565de621dad7ccd07a24f4c1aaae168377e973cb2abeb4c749)
BibTeX
@misc{dca0c4988aedee,
title = {Repurposing Metformin in Precision Oncology: Mechanistic Insights, Biomarker-Guided Strategies, and Translational Imperatives — Europe PMC PMID:41010968},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41010968},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a0c4988aedee; sha256 a6675ea1c0d97b565de621dad7ccd07a24f4c1aaae168377e973cb2abeb4c749},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41010968. Agents can read the archived copy with the MCP tool read_document.